KO (I-KO) mouse model with which to evaluate the role of intestinal ZIP14 on Mn absorption 1 0 5 and excretion. 1 0 6
Treatments. Following four h of morning fasting, mice were administered 54 Mn either via gavage 1 0 7 (5 µCi) or subcutaneous injections (3 µCi). Four h later, the mice were euthanized via cardiac 1 0 8 puncture to collect blood and tissues. The entire excised small intestine was perfused with a 1 0 9 metal chelating buffer (10 mM EDTA, 10 mM HEPES and 0.9% NaCl2). The 54 Mn content of 1 1 0 tissues was measured by gamma-ray solid scintillation spectrometry and normalized by tissue 1 1 1 weight. Manganese exposure: Either control or Mn-supplemented (2mg Mn/L as MnCl 2 ) water 1 1 2 was provided to the mice for one month. We chose to supplement Mn via the drinking water to 1 1 3 maintain a relatively constant consumption of the diet. Genotyping. Genomic DNA was extracted 1 1 4 from mouse tail biopsies using extraction buffer (25mM NaOH / 0.2 mM EDTA) and incubation 1 1 5 at 98ºC for 45 min (33). The genotyping protocol for whole body Zip14 KO mice has been 1 1 6 presented previously (2). Following primer sets were used for genotyping Zip14 fl/fl and Villin-1 1 7 Cre+ mice: Flox-Forward 5'-AGT GGC CAT GGT AGT TCC TG-3', Flox-Reverse 5 -CCT GGT 1 1 8 GCC TGC ATA TTC TC-3' and Cre-Reverse 5'-CAT GTC CAT CAG GTT CTT GC-3', Cre-1 1 9
Forward 5'-TTC TCC TCT AGG CTC GTC CA-3', Internal Positive Control Forward 5'-CTA 1 2 0 GGC CAC AGA ATT GAA AGA TCT-3', Internal Positive Control Reverse 5'-GTA GGT GGA 1 2 1 AAT TCT AGC ATC ATC C-3', respectively. 1 2 2 Metal Assays. To measure Mn concentrations, weighed aliquots of tissue were digested at 95°C 1 2 3 for at least 3 h in HNO 3 . Whole blood (500µL) was dried and then digested for 24 h in HNO 3. 1 2 4
The entire excised small intestine was perfused with a metal chelating buffer (10 mM EDTA, 10 1 2 5 mM HEPES and 0.9% NaCl2) (equal volume/intestine), then digested for 24 h in HNO 3. 1 2 6
Digested samples were diluted in Milli-Q water. Mn was measured by Microwave Plasma-1 2 7
Atomic Emission Spectrometry (MP-AES) using 403.076 nm for emission detection. 1 2 8
Normalization was to tissue or body weight (intestinal contents). 1 2 9 ROS assay. Whole brain tissues were homogenized in lysis buffer (250 mM Sucrose 1 3 0 20 mM HEPES-NaOH, PH: 7.5, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM EDTA, 1 mM EGTA) that 1 3 1 supplemented with protease inhibitors. Following centrifugation at 800 x g for 10 min, 1 3 2 supernatants were incubated with 2,7-Dichlorodihydrofluorescein diacetate (Cayman 4091-99-0) 1 3 3 at 37 ºC for an h. The fluorescent signal was measured at 502/523 nm. 1 3 4
Western blot. Tissue was homogenized in lysis buffer with protease and phosphatase inhibitors 1 3 5 (Thermo Scientific and AGScientific) added along with the PMSF (Sigma-Aldrich) using the 1 3 6
Bullet Blender (Next Advances). Solubilized proteins were separated by 10% SDS-PAGE. 1 3 7
Visualization was by chemiluminescence (SuperSignal, Thermo Fisher) and digital imaging 1 3 8 (Protein Simple). Rabbit anti-mouse ZIP14 antibody was custom made by Genscript. Antibodies 1 3 9
for GAPDH and actin were obtained from Cell Signalling. 1 4 0
Quantitative PCR analyses. Tissues were homogenized in TRIzol reagent using the Bullet 1 4 1 Blender homogenizer and RNA was isolated. Total RNA was used to measure relative mRNA 1 4 2 abundance by quantitative PCR (qPCR). Primer/probes for iNOS, tnfα, il6, and gapdh were 1 4 3 purchased from Applied Biosystems. 1 4 4
Motor Function. Motor functions were tested in the light-phase. All tests were performed as in 1 4 5 previous studies (3). Beam Traversal. The beam was constructed of four segments of 0.25 m in 1 4 6 length. Each segment was of thinner widths 3.5 cm, 2.5 cm, 1.5 cm, and 0.5 cm; The widest 1 4 7 segment acted as a loading platform for the mice, and the narrowest end was adjacent to the 1 4 8 home cage. After two days of training, on the test day, mice were timed over three trials to 1 4 9 traverse from the loading platform and to the home cage. Pole Descent. A pole (0.5 m long, 1 1 5 0 cm in diameter) was placed in the home cage. After two days of training, on the test day, the 1 5 1 time to descend from the top of the pole to the cage floor was measured. Fecal output. Mice 1 5 2 were transferred from their home cage to a 12X20 cm translucent cylinder, and fecal pellets 1 5 3 produced over 5 min were counted. The data were generated by using averages of three days 1 5 4 of trials. Inverted grid. The mice were placed in the center of a 26 by 38 cm screen with 1-cm 2 -1 5 5
wide mesh. The screen was inverted for 60 s, and the mice were timed until they released their 1 5 6 grip or held on. 1 5 7 3-4% isoflurane delivered in medical grade air (70% nitrogen, 30% oxygen; air flow rate 1.5 1 6 5 mL/min). The anesthesia was maintained at 1.0-1.5% isoflurane during MRI scanning. Core 1 6 6 body temperature and spontaneous respiratory rates were continuously recorded during MRI 1 6 7 scanning (SA Instruments, Stony Brook, NY). Mice were maintained at normal body 1 6 8 temperature levels (37-38 °C) using a warm water recirculation system. The MRI included a 1 6 9 multiple repetition time sequence to calculate parametric T 1 maps for each group using a fast 1 7 0 spin echo sequence with a total of four TR's (0.5, 1.08, 2.33, 5.04 seconds), and TE = 6.02 ms 1 7 1 with the following geometric parameters: 16 x 16 mm 2 in plane, 14 slices at 0.8 mm thickness 1 7 2 per slice, data matrix = 128 x 128 (125 μ m in-plane resolution). 1 7 3 MRI Post-Processing and analysis. Whole brain masks were obtained via automated 1 7 4 segmentation with 3-dimensional pulse-coupled neural networks (PCNN3D) using high-1 7 5 resolution anatomical scans to remove non-brain voxels. All cropped data were used to create 1 7 6 templates for each cohort using Advanced Normalization Tools (ANTs; 1 7 7 http://stnava.github.io/ANTs/). The templates were then registered to an atlas of the mice brain 1 7 8 using the FMRIB Software Library linear registration program flirt. The atlas was then 1 7 9 transformed back to each individual data set with the registration matrices from ANTS. To 1 8 0 generate parametric T1 maps, multi-TR images were fit to the equation S TR =S 0 (1-e -TR/T1 ) using 1 8 1 A representative PCR amplification for genotyping was shown in Fig. 1A . Intestine-1 9 0 specific ablation of Zip14 was confirmed by western blotting of ZIP14 protein. Tissues from both 1 9 1 VC and fl/fl mice were included as controls. ZIP14 was deleted only in the intestine of the I-KO 1 9 2 mice (Fig. 1B) . Western blotting shows expression of ZIP14 between I-KO and WB-KO mice 1 9 3 (Fig. 1C) . Absence of ZIP14 from only the intestine of the I-KO mice confirms tissue specificity. 1 9 4
To determine the role of intestinal ZIP14 in Mn clearance, we conducted 54 Mn uptake studies 1 9 5 using I-KO mice to assertain the direction of Mn transport mediated by ZIP14. 54 Mn was 1 9 6 administered via two routes, and radioactivity in the intestine was measured. There was no 1 9 7 difference in the amount of radioactivity in the intestine of I-KO, VC, and fl/fl mice when 54 Mn 1 9 8 was administered via oral gavage (Fig. 1D) , indicating that intestinal 54 Mn absorption was not 1 9 9 affected by ZIP14 deficiency. However, significantly (p<0.001) less radioactivity was detected in 2 0 0 the intestine of Zip14 I-KO mice when 54 Mn was administered via sc injection, indicating that the 2 0 1 intestine-specific deletion of Zip14 decreased serosal to mucosal transcellular Mn transport. In 2 0 2 the following experiments, fl/fl mice were used as controls since we have confirmed that there 2 0 3 was no difference in 54 Mn uptake between fl/fl and VC mice (Fig. 1D ). 2 0 4
Deletion of intestinal Zip14 leads to systemic and brain Mn accumulation. 2 0 5
To test whether impaired intestinal ZIP14-mediated Mn excretion affects systemic Mn 2 0 6 metabolism, we compared systemic 54 Mn distribution between WB-KO and I-KO mice. Our 2 0 7 results revealed that when it was given via s.c. injection, the amount of 54 Mn was significantly 2 0 8 less in the intestines of both WB-and I-KO mice ( Fig. 2A) . Furthermore, the amount of 54 Mn was 2 0 9 significantly greater in the blood and brain of the WB and I-KO mice when compared to their 2 1 0 controls (Fig. 2B) . The magnitude of increase in 54 Mn was less in I-KO mice compared to WB-2 1 1
The key route of Mn elimination is through the hepatobiliary system. To evaluate the 2 1 3 hepatobiliary clearance of Mn, we measured liver 54 Mn uptake. Of note 54 Mn uptake was 2 1 4 impaired in WB-KO and enhanced in I-KO, suggesting that a lack of intestinal ZIP14 was 2 1 5 compensated for in the I-KO mice through increased Mn elimination via the hepatobiliary system 2 1 6 ( Fig. 2C ). Furthermore, 54 Mn uptake was not different between kidney and pancreas of fl/fl and 2 1 7 I-KO mice, while 54 Mn uptake was higher and lower in pancreas and kidney of WB-KO, 2 1 8 respectively suggesting that ZIP14 might be involved with 54 Mn uptake in the kidney (Fig. 2D ). 2 1 9
Next, to evaluate the influence of intestinal ZIP14 on brain Mn, we measured Mn 2 2 0 accumulation using MP-AES. The Mn concentration was greater in the blood and brain of both 2 2 1 the WB-KO and I-KO mice compared to their controls (Fig. 3A) . As expected, relative 2 2 2 accumulation was less in the I-KO mice. Furthermore, we used MRI analysis to evaluate brain 2 2 3
Mn accumulation between WB-KO and I-KO mice. Signal intensity was greater in the brains of 2 2 4 I-KO when compared to fl/fl. Similar to 54 Mn uptake and MP-AES data, the differences in MRI 2 2 5 signal intensity between the brains of the fl/fl and I-KO were less than that of between the WB-2 2 6 KO and WTmice (Fig. 3B) . Nevertheless, the images from the I-KO mice clearly show punctate 2 2 7 regions of increased intensity consistent with Mn accumulation. Of note, the MRI images 2 2 8 reflected endogenous Mn in brains of both genotypes obtained without any enhancement and 2 2 9
were from young adult mice maintained under barrier conditions with normal husbandry. These 2 3 0 data collectively suggest that deletion of intestinal Zip14 was sufficient to cause systemic Mn 2 3 1 overload and that intestinal ZIP14 is a significant contributor to Mn homeostasis. 2 3 2 Neuroinflammation and motor dysfunction in intestine-specific Zip14 KO is amplified 2 3 3 with high Mn exposure. 2 3 4
Deletion of intestinal Zip14 caused systemic and brain Mn overload; however, the 2 3 5 magnitude of increases was less in I-KO compared to WB-KO. Therefore, we have conducted 2 3 6
Mn supplementation studies with I-KO mice to increase exposure. Deletion of intestinal ZIP14 2 3 7 was confirmed by western blot (Fig. 4A) . Following Mn-exposure, increased intestinal Mn 2 3 8 concentrations were found in the fl/fl mice, but were not observed in the I-KO mice (Fig. 4A ).
3 9
Moreover, the Mn concentration of luminal and fecal content of Mn-supplemented I-KO was 2 4 0 significantly less than Mn-supplemented fl/fl mice (Fig. 4B) . Mn concentrations were greater in 2 4 1 the liver of I-KO mice compared fl/fl mice in the control group demonstrating greater hepatic Mn 2 4 2 clearance occurs when hepatic ZIP14 is functional and intestinal ZIP14 is not (Fig. 4C ).
4 3
Mn is neurotoxic; thus, we next measured the blood and brain Mn concentrations. Mn 2 4 4 concentrations were greater in blood and brain of I-KO mice compared fl/fl mice in the control 2 4 5 group (Fig. 5A, B ). Mn concentrations in Mn-supplemented fl/fl mice were comparable to the I-2 4 6 KO unsupplemented mice. Mn-supplementation further enhanced the Mn accumulation in blood 2 4 7 and brain of I-KO mice compared to Mn-supplemented fl/fl mice, however. Importantly there was 2 4 8 no change between groups in brain Zn and Fe concentrations (Fig. 5C ). Importantly, the Mn- 
